Literature DB >> 15515887

Partial activation of a silent angucycline-type gene cluster from a rubromycin beta producing Streptomyces sp. PGA64.

Mikko Metsä-Ketelä1, Kristiina Ylihonko, Pekka Mäntsälä.   

Abstract

In the course of DNA-fingerprinting our strain collection for antibiotic biosynthesis genes, two different type II polyketide synthase (PKS) gene clusters were observed from Streptomyces sp. PGA64. Phylogenetic analysis placed these together with known rubromycin and angucycline biosynthetic gene clusters. The host strain itself has a very clean production profile of secondary metabolites, which composes mainly of rubromycin beta under typical fermentation conditions. Sequencing of a 16.5 kb fragment from the putative angucycline cluster revealed eight genes that were homologous to typical type II PKS genes responsible for synthesizing aromatic polyketides. These genes were especially similar to genes from known angucycline biosynthetic gene clusters and also synteny to these clusters was observed. In addition, three genes were recognized that are needed for priming the minimal PKS complex before polyketide synthesis can initiate, but which are not normally found to cluster with antibiotic biosynthesis genes. A putative repressor gene that was dissimilar to repressor genes found from well-characterized antibiotic biosynthesis gene clusters was also discovered. Gene disruption of the repressor resulted in partial activation of the cluster and production of two angucycline metabolites, UWM6 and rabelomycin. The results confirm that the DNA-fingerprinting method we have developed can be used to correctly detect compounds that are not visible in chemical screens.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15515887     DOI: 10.7164/antibiotics.57.502

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  9 in total

Review 1.  The TetR family of regulators.

Authors:  Leslie Cuthbertson; Justin R Nodwell
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

2.  Identification of the function of gene lndM2 encoding a bifunctional oxygenase-reductase involved in the biosynthesis of the antitumor antibiotic landomycin E by Streptomyces globisporus 1912 supports the originally assigned structure for landomycinone.

Authors:  Lili Zhu; Bohdan Ostash; Uwe Rix; Mohammad Nur-E-Alam; Almuth Mayers; Andriy Luzhetskyy; Carmen Mendez; Jose A Salas; Andreas Bechthold; Victor Fedorenko; Jürgen Rohr
Journal:  J Org Chem       Date:  2005-01-21       Impact factor: 4.354

3.  Genetic manipulation of pathway regulation for overproduction of angucycline-like antibiotic auricin in Streptomyces aureofaciens CCM 3239.

Authors:  Renata Novakova; Alena Rehakova; Lubomira Feckova; Peter Kutas; Renata Knischova; Jan Kormanec
Journal:  Folia Microbiol (Praha)       Date:  2011-05-17       Impact factor: 2.099

Review 4.  Molecular regulation of antibiotic biosynthesis in streptomyces.

Authors:  Gang Liu; Keith F Chater; Govind Chandra; Guoqing Niu; Huarong Tan
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

5.  Activation and mechanism of a cryptic oviedomycin gene cluster via the disruption of a global regulatory gene, adpA, in Streptomyces ansochromogenes.

Authors:  Jingjing Xu; Jihui Zhang; Jiming Zhuo; Yue Li; Yuqing Tian; Huarong Tan
Journal:  J Biol Chem       Date:  2017-09-25       Impact factor: 5.157

6.  Cloning and Heterologous Expression of the Grecocycline Biosynthetic Gene Cluster.

Authors:  Oksana Bilyk; Olga N Sekurova; Sergey B Zotchev; Andriy Luzhetskyy
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

Review 7.  Concepts and Methods to Access Novel Antibiotics from Actinomycetes.

Authors:  Joachim J Hug; Chantal D Bader; Maja Remškar; Katarina Cirnski; Rolf Müller
Journal:  Antibiotics (Basel)       Date:  2018-05-22

Review 8.  The Sound of Silence: Activating Silent Biosynthetic Gene Clusters in Marine Microorganisms.

Authors:  F Jerry Reen; Stefano Romano; Alan D W Dobson; Fergal O'Gara
Journal:  Mar Drugs       Date:  2015-07-31       Impact factor: 5.118

9.  Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor.

Authors:  Hani A Alhadrami; Ahmed M Sayed; Heba Al-Khatabi; Nabil A Alhakamy; Mostafa E Rateb
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.